Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 116.00 | |
2 mg | In stock | $ 169.00 | |
5 mg | In stock | $ 289.00 | |
10 mg | In stock | $ 478.00 | |
25 mg | In stock | $ 789.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,480.00 | |
500 mg | In stock | $ 2,970.00 |
Description | Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer. |
Synonyms | HMPL-813 succinate |
Molecular Weight | 548.59 |
Formula | C28H32N6O6 |
CAS No. | 2252334-12-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11.7 mg/mL (21.3 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Epitinib succinate 2252334-12-4 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR HMPL-813 succinate HMPL 813 Succinate HMPL813 Succinate HMPL-813 Succinate Epitinib Succinate inhibitor inhibit